The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...
Findings from an exploratory 2a study showed improvements in patients with cancer cachexia with PH284 compared with placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback